Josh is a member of HMB’s Business and Finance Group where he focuses on commercial finance, transactions, private equity and venture capital matters.
Josh works closely with privately-held companies, venture capital funds, high-growth businesses and their executives and investors. He takes a practical approach when counseling clients on all types of transactional and financing matters.
Greater Clarity with Fewer Surprises
Clients appreciate Josh’s strong financial and business management background to guide them through their sophisticated financings and transactions with great clarity and fewer surprises.
University of Illinois at Urbana-Champaign, B.A., Economics
DePaul University Kellstadt Graduate School of Business, M.B.A., with Distinction, Finance
DePaul University College of Law, J.D.
5/14/18 2018 Startup Showcase (District 214) Forest View Educational Center Arlington Heights, Illinois Josh Haberkorn participated as a judge in High School District 214's Startup Showcase, which gives students from six high schools the opportunity to pitch their business ventures following a year's worth of critical thinking, collaboration and innovation in the District's entrepreneurship program.…
Mark-It Express Logistics LLC ("Mark-It"), a leading Midwest intermodal trucking and freight brokerage company, acquired Spirit Trucking Company ("Spirit"), a Chicago-based trucking company. HMB represented Mark-It in the acquisition of operating assets. Mark-It, founded in 2009 and recently named to Crain Chicago's Fast 50 for the second time and INC. 5000 for the fourth time, offers a full array of third-party…
HMB represented EDCO Health Information Solutions Inc. in it's sale to BV Investment Partners, a middle-market private equity firm focused on the business services, software and IT sectors. Headquartered in St. Louis, MO, EDCO provides automated unstructured data indexing solutions to healthcare providers. EDCO's Solarity®, a patented medical record indexing software, gives automated transformation of unstructured data into clinically relevant patient…